Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in J Thorac Cardiovasc Surg Retrieve available abstracts of 42 articles: HTML format

Single Articles

June 2025
1. MEHTA R, Reitz JG, d'Udekem Y
   Reply: The evolving role of artificial intelligenge in pediatric cardiovascular surgery: A call for transparency, collaboration, and rigorous validation.
   J Thorac Cardiovasc Surg. 2025 Jun 11:S0022-5223(25)00294.
   PubMed    
   
   
   
2. DAYAN V, Hernandez M, Montero JA, Sosa C, et al
   Long-Term Outcomes of Patients Undergoing Multi-Arterial Grafting in Coronary Artery Bypass Grafting: Insights from a Latin American National Cohort.
   J Thorac Cardiovasc Surg. 2025 Jun 9:S0022-5223(25)00466.
   PubMed     Abstract available
   
   
   
3. NISIVACO S, Kitahara H, Bhasin R, Patel B, et al
   A decade of robotic beating-heart totally endoscopic coronary bypass (TECAB) at a single institution: Outcomes with 10-year follow-up.
   J Thorac Cardiovasc Surg. 2025;169:1753-1760.
   PubMed     Abstract available
   
   
   April 2025
4. CHAE MC, Yoon S, Lee HJ, Jang WS, et al
   Outcomes of Ischemic Mitral Regurgitation after Coronary Revascularization Alone in Patients with Acute Coronary Syndrome.
   J Thorac Cardiovasc Surg. 2025 Apr 24:S0022-5223(25)00336.
   PubMed     Abstract available
   
   
   
5. KACZOROWSKI DJ, Takeda K, Atluri P, Cevasco M, et al
   2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical Management of Acute Myocardial Infarction and Associated Complications.
   J Thorac Cardiovasc Surg. 2025 Apr 16:S0022-5223(25)00302.
   PubMed     Abstract available
   
   
   
6. LEE JH, Kim HJ
   Reply: Preoperative diabetes duration and long-term outcomes in patients with acute myocardial infarction undergoing coronary artery bypass grafting.
   J Thorac Cardiovasc Surg. 2025 Apr 4:S0022-5223(25)00206.
   PubMed    
   
   
   March 2025
7. ZHANG X, Wang J
   Ensuring safety and reliability in ChatGPT-assisted pediatric cardiovascular surgical decision-making.
   J Thorac Cardiovasc Surg. 2025 Mar 31:S0022-5223(25)00175.
   PubMed    
   
   
   
8. SILVA CAMPOS AA, da Silveira Maia A, Vilca Mejia OA
   Building knowledge through guidelines: A discussion about coronary artery bypass grafting recommendations in 2025.
   J Thorac Cardiovasc Surg. 2025 Mar 25:S0022-5223(25)00188.
   PubMed    
   
   
   
9. QI M, Yang X
   Refining preoperative diabetes assessment: Implications for acute myocardial infarction-coronary artery bypass grafting management and long-term outcomes.
   J Thorac Cardiovasc Surg. 2025 Mar 21:S0022-5223(25)00177.
   PubMed    
   
   
   February 2025
10. NORMAN AV, Kron IL
    Reply: Saving hearts: Utilizing cardiac catheterization after coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Feb 22:S0022-5223(25)00095.
    PubMed    
    
    
    
11. DELL'AQUILA AM, Dell'Aquila M, Calafiore AM
    Unplanned postoperative catheterization after coronary artery bypass graft: Improving quality of care.
    J Thorac Cardiovasc Surg. 2025 Feb 10:S0022-5223(25)00038.
    PubMed    
    
    
    January 2025
12. LEE JH, Kim YJ, Cho YH, Kim JB, et al
    Preoperative diabetic duration and long-term outcomes in acute myocardial infarction patients undergoing coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Jan 31:S0022-5223(25)00091.
    PubMed     Abstract available
    
    
    
13. MEHTA R, Reitz JG, Venna A, Selcuk A, et al
    Navigating the Future of Pediatric Cardiovascular surgery: Insights and Innovation powered by ChatGPT.
    J Thorac Cardiovasc Surg. 2025 Jan 31:S0022-5223(25)00093.
    PubMed     Abstract available
    
    
    
14. NISIVACO S, Lysyy T, Kruse J, Cox JL, et al
    Surgical Treatment of Atrial Fibrillation in Coronary Artery Bypass Grafting.
    J Thorac Cardiovasc Surg. 2025 Jan 22:S0022-5223(25)00037.
    PubMed    
    
    
    
15. BRLECIC PE, Sylvester CB, Hogan KJ, Zhang Q, et al
    Low socioeconomic status adversely affects outcomes after coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Jan 19:S0022-5223(25)00033.
    PubMed     Abstract available
    
    
    
16. PATIL AR, Zheng A, Israel Y, Shah A, et al
    Computed tomography coronary angiography as an alternative to invasive coronary angiography in preoperative evaluation for mitral surgery.
    J Thorac Cardiovasc Surg. 2025 Jan 19:S0022-5223(25)00030.
    PubMed     Abstract available
    
    
    
17. PEGUES JN, Chang CH, Alnajjar RM, Zhou S, et al
    Disparities in 180-day Infection Rates Following Coronary Artery Bypass Grafting and Aortic Valve Replacement.
    J Thorac Cardiovasc Surg. 2025 Jan 15:S0022-5223(25)00017.
    PubMed     Abstract available
    
    
    
18. 
    Commentator Discussion: Revascularization after minimally invasive coronary artery bypass grafting in 566 patients: Is it a problem?
    J Thorac Cardiovasc Surg. 2025 Jan 15:S0022-5223(24)01197.
    PubMed    
    
    
    
19. DAYAN V, Sabik JF 3rd, Ono M, Ruel M, et al
    Multisociety endorsement of the 2024 European guideline recommendations on coronary revascularization.
    J Thorac Cardiovasc Surg. 2025 Jan 9:S0022-5223(24)00990.
    PubMed    
    
    
    
20. 
    Commentator Discussion: The impact of epiaortic ultrasound utilization in patients undergoing coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2025 Jan 6:S0022-5223(24)01124.
    PubMed    
    
    
    
21. 
    Commentator Discussion: Multiarterial grafting in redo coronary artery bypass grafting: Type of arterial conduit and patient sex determine benefit.
    J Thorac Cardiovasc Surg. 2025 Jan 5:S0022-5223(24)01123.
    PubMed    
    
    
    December 2024
22. STEWART JW 2ND, Forrester M, Hawkins RB
    Erratum to "Discussion to: del Nido versus blood cardioplegia in cardiac surgery: A multicenter analysis of over 40,000 patients" [The Journal of Thoracic and Cardiovascular Surgery Volume 168, Issue 6, December 2024, Pages 1698-1700].
    J Thorac Cardiovasc Surg. 2024 Dec 31:S0022-5223(24)01141.
    PubMed    
    
    
    
23. KIM HR, Kim HJ, Kim S, Kim Y, et al
    Corrigendum to 'Bovine pericardial versus porcine bioprosthetic aortic valves: A nationwide population-based cohort study in Korea'[The Journal of Thoracic and Cardiovascular Surgery Volume 168, Issue 5, November 2024, Pages 1438-1447.e4].
    J Thorac Cardiovasc Surg. 2024 Dec 31:S0022-5223(24)01137.
    PubMed    
    
    
    
24. ALTORKI N, Wang X, Damman B, Mentlick J, et al
    Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 202
    J Thorac Cardiovasc Surg. 2024 Dec 20:S0022-5223(24)01142.
    PubMed    
    
    
    
25. MARIANI S, Ravaux JM, van Bussel BCT, De Piero ME, et al
    Features and outcomes of female and male patients requiring postcardiotomy extracorporeal life support.
    J Thorac Cardiovasc Surg. 2024;168:1701-1711.
    PubMed     Abstract available
    
    
    November 2024
26. TOUBAR O, Guo MH, Ashenhurst C, Ponnambalam M, et al
    Revascularization after Minimally Invasive Coronary Artery Bypass Grafting in 566 Patients: Is It a Problem?
    J Thorac Cardiovasc Surg. 2024 Nov 25:S0022-5223(24)01093.
    PubMed     Abstract available
    
    
    
27. HARRIS DD, Broadwin M, Sabe SA, Stone C, et al
    Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozin.
    J Thorac Cardiovasc Surg. 2024;168:e183-e199.
    PubMed     Abstract available
    
    
    
28. JAVORSKI MJ, Bauza K, Xiang F, Soltesz E, et al
    Identifying and mitigating risk of postcardiotomy cardiogenic shock in patients with ischemic and nonischemic cardiomyopathy.
    J Thorac Cardiovasc Surg. 2024;168:1489-1499.
    PubMed     Abstract available
    
    
    October 2024
29. GADELKARIM I, Kuzmenko V, de Waha S, Deshmukh N, et al
    Outcomes of Single versus Sequential Vein Grafts in Isolated Coronary Artery Bypass Surgery: Insights from a Large Tertiary Care Center.
    J Thorac Cardiovasc Surg. 2024 Oct 25:S0022-5223(24)00936.
    PubMed     Abstract available
    
    
    
30. YOUSEF S, Sultan I, Thoma F, Wang Y, et al
    The Impact of Epiaortic Ultrasound utilization in patients undergoing Coronary Artery Bypass Grafting.
    J Thorac Cardiovasc Surg. 2024 Oct 25:S0022-5223(24)00983.
    PubMed     Abstract available
    
    
    
31. 
    Commentator Discussion: Chronic total occlusions and coronary artery bypass grafting outcomes.
    J Thorac Cardiovasc Surg. 2024 Oct 18:S0022-5223(24)00791.
    PubMed    
    
    
    September 2024
32. CLAUS J, Schoof L, Mir TS, Kammal AL, et al
    Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death.
    J Thorac Cardiovasc Surg. 2024 Sep 19:S0022-5223(24)00814.
    PubMed     Abstract available
    
    
    
33. HEIMA D, Takeda M, Tabata Y, Minatoya K, et al
    Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;168:e72-e88.
    PubMed     Abstract available
    
    
    August 2024
34. ROMEO JL, Vriesendorp PA, Gerritsen K, Nader M, et al
    Modeling creatine-kinase MB concentrations following coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2024 Aug 20:S0022-5223(24)00703.
    PubMed     Abstract available
    
    
    
35. KAWCZYNSKI MJ, Gabrio A, Maessen JG, van 't Hof AWJ, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary bypass surgery for coronary artery disease: a Bayesian perspective.
    J Thorac Cardiovasc Surg. 2024 Aug 20:S0022-5223(24)00701.
    PubMed     Abstract available
    
    
    
36. GIKANDI A, Stock EM, Dematt E, Quin J, et al
    Chronic Total Occlusions and Coronary Artery Bypass Grafting Outcomes.
    J Thorac Cardiovasc Surg. 2024 Aug 20:S0022-5223(24)00700.
    PubMed     Abstract available
    
    
    July 2024
37. DE FILIPPO O, Di Franco A, Improta R, Di Pietro G, et al
    Percutaneous coronary intervention versus coronary artery bypass grafting for left main disease according to age: a meta-analysis.
    J Thorac Cardiovasc Surg. 2024 Jul 25:S0022-5223(24)00654.
    PubMed    
    
    
    
38. NGUYEN SN, Vinogradsky AV, Tao AM, Chung MM, et al
    Rare Coronary Artery Variants are Associated with Increased Mortality and Reinterventions Following the Arterial Switch Operation.
    J Thorac Cardiovasc Surg. 2024 Jul 12:S0022-5223(24)00611.
    PubMed     Abstract available
    
    
    April 2024
39. GAUDINO M, Bairey Merz CN, Sandner S, Creber RM, et al
    Randomized Comparison of the Outcome of Single Versus Multiple Arterial Grafts trial (ROMA):Women-a trial dedicated to women to improve coronary bypass outcomes.
    J Thorac Cardiovasc Surg. 2024;167:1316-1321.
    PubMed    
    
    
    
40. LACOUR-GAYET F
    Influence of coronary arteries transfer on the geometry of the neoaortic root in arterial switch.
    J Thorac Cardiovasc Surg. 2024 Apr 1:S0022-5223(24)00203.
    PubMed    
    
    
    March 2024
41. ALZAHRANI AH, Itagaki S, Egorova N, Chikwe J, et al
    Choice of revascularization strategy for ischemic cardiomyopathy due to multi-vessel coronary disease.
    J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00208.
    PubMed     Abstract available
    
    
    August 2023
42. KING CL, Onohara D, Tom SK, Silverman M, et al
    Transapical Ventricular Reshaping Reduces Functional Mitral Regurgitation and Improves Ventricular Function in a Preclinical Model of Ischemic Cardiomyopathy.
    J Thorac Cardiovasc Surg. 2023 Aug 17:S0022-5223(23)00724.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.